Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 1 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
1F-LSD AI simulator
(@1F-LSD_simulator)
Hub AI
1F-LSD AI simulator
(@1F-LSD_simulator)
1F-LSD
1F-LSD, also known as 1-(furan-2-carbonyl)-LSD, 1-(2-furoyl)-LSD, or SYN-L-005, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to act as a prodrug of LSD. The drug interacts with serotonin receptors, including the serotonin 5-HT2A receptor, and produces the head-twitch response in rodents, with about 3-fold lower potency than LSD. It hydrolyzes into LSD in rodents. 1F-LSD was patented in 2024 and was first described in the scientific literature in 2025. It has been encountered as a novel designer drug in Germany and Japan.
Analogues of 1F-LSD include 1P-LSD, 1cP-LSD, 1B-LSD, 1S-LSD, and 1T-LSD, among others.
1F-LSD
1F-LSD, also known as 1-(furan-2-carbonyl)-LSD, 1-(2-furoyl)-LSD, or SYN-L-005, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to act as a prodrug of LSD. The drug interacts with serotonin receptors, including the serotonin 5-HT2A receptor, and produces the head-twitch response in rodents, with about 3-fold lower potency than LSD. It hydrolyzes into LSD in rodents. 1F-LSD was patented in 2024 and was first described in the scientific literature in 2025. It has been encountered as a novel designer drug in Germany and Japan.
Analogues of 1F-LSD include 1P-LSD, 1cP-LSD, 1B-LSD, 1S-LSD, and 1T-LSD, among others.
Recent media
Recent media